PTO Form 1553 (Rev 5/2006) |
OMB No. 0651-0055 (Exp 12/31/2011) |
Declaration of Use and/or Excusable Nonuse of Mark in Commerce under Section 8
The table below presents the data as entered.
Input Field
|
Entered
|
REGISTRATION NUMBER |
2977968 |
REGISTRATION DATE |
07/26/2005 |
SERIAL NUMBER |
76573827 |
MARK SECTION |
MARK |
VELIVET |
CORRESPONDENCE SECTION (current) |
NAME |
TRACY-GENE G. DURKIN |
FIRM NAME |
STERNE, KESSLER, GOLDSTEIN |
STREET |
1100 NEW YORK AVENUE, N.W. |
CITY |
WASHINGTON |
STATE |
District of Columbia |
POSTAL CODE |
20005-3934 |
COUNTRY |
United States |
PHONE |
(202) 772-8660 |
FAX |
202.371.2540 |
EMAIL |
TDURKIN@SKGF.COM |
CORRESPONDENCE SECTION (proposed) |
NAME |
Herschel Perel |
FIRM NAME |
Teva Pharmaceuticals USA |
INTERNAL ADDRESS |
Trademarks Department |
STREET |
425 Privet Road |
CITY |
Horsham |
STATE |
Pennsylvania |
POSTAL CODE |
19044 |
COUNTRY |
United States |
PHONE |
215-293-6406 |
FAX |
215-293-6499 |
EMAIL |
herschel.perel@tevausa.com |
AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
DOCKET/REFERENCE NUMBER |
2977968 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
GOODS OR SERVICES |
Pharmaceuticals, namely, oral contraceptives and pharmaceuticals for hormone replacement therapy |
SPECIMEN FILE NAME(S) |
ORIGINAL PDF FILE |
SPN0-681771705-100417342_._USA_Velivet.pdf |
CONVERTED PDF FILE(S)
(1 page) |
\\TICRS\EXPORT11\IMAGEOUT11\765\738\76573827\xml5\S080002.JPG |
SPECIMEN DESCRIPTION |
product label that has the name of the product printed on it. |
MISCELLANEOUS STATEMENT |
Free text not entered by the applicant. |
ORIGINAL PDF FILE |
MISC-681771705-100417342_._USA_Velivet.pdf |
|
\\TICRS\EXPORT11\IMAGEOUT 11\765\738\76573827\xml5\ S080003.JPG |
OWNER SECTION (current) |
NAME |
Barr Laboratories, Inc. |
STREET |
2 Quaker Road |
CITY |
Pomona |
STATE |
New York |
ZIP/POSTAL CODE |
10970 |
COUNTRY |
United States |
OWNER SECTION (proposed) |
NAME |
Barr Laboratories, Inc. |
STREET |
400 Chestnut Ridge Road |
CITY |
Woodcliff Lake |
STATE |
New Jersey |
ZIP/POSTAL CODE |
07677 |
COUNTRY |
United States |
PHONE |
215-293-6406 |
FAX |
215-293-6499 |
EMAIL |
XXXX |
AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
LEGAL ENTITY SECTION (current) |
TYPE |
corporation |
STATE/COUNTRY OF INCORPORATION |
Delaware |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
NUMBER OF CLASSES PAID |
1 |
SUBTOTAL AMOUNT |
100 |
TOTAL FEE PAID |
100 |
SIGNATURE SECTION |
SIGNATURE |
/herschel perel/ |
SIGNATORY'S NAME |
Herschel Perel |
SIGNATORY'S POSITION |
Senior Director, Global Trademarks |
DATE SIGNED |
06/23/2011 |
PAYMENT METHOD |
DA |
FILING INFORMATION |
SUBMIT DATE |
Thu Jun 23 10:17:08 EDT 2011 |
TEAS STAMP |
USPTO/SECT08-XX.XXX.XXX.X
-20110623101708590698-297
7968-48089b76549a9486ea64
d2fee1238967998-DA-9145-2
0110623100417342220 |
PTO Form 1553 (Rev 5/2006) |
OMB No. 0651-0055 (Exp 12/31/2011) |
Declaration of Use and/or Excusable Nonuse of Mark in Commerce under Section 8
To the Commissioner for Trademarks:
REGISTRATION NUMBER: 2977968
REGISTRATION DATE: 07/26/2005
MARK: VELIVET
The owner, Barr Laboratories, Inc., a corporation of Delaware, having an address of
400 Chestnut Ridge Road
Woodcliff Lake, New Jersey 07677
United States
is filing a Declaration of Use and/or Excusable Nonuse of Mark in Commerce under Section 8.
For International Class 005, the mark is in use in commerce on or in connection with
all goods or services listed in the existing registration for this specific class: Pharmaceuticals, namely,
oral contraceptives and pharmaceuticals for hormone replacement therapy ; or, the owner is making the listed excusable nonuse claim.
The owner is submitting one specimen showing the mark as used in commerce on or in connection with any item in this class, consisting of a(n) product label that has the name of the product printed on
it..
Original PDF file:
SPN0-681771705-100417342_._USA_Velivet.pdf
Converted PDF file(s) (1 page)
Specimen File1
MISCELLANEOUS STATEMENTS
Free text not entered by the applicant.
Original PDF file:
MISC-681771705-100417342_._USA_Velivet.pdf
Converted PDF file(s) (1 page)
Miscellaneous File1
The registrant's current Correspondence Information: TRACY-GENE G. DURKIN of STERNE, KESSLER, GOLDSTEIN
1100 NEW YORK AVENUE, N.W.
WASHINGTON, District of Columbia (DC) 20005-3934
United States (USX)
The registrant's proposed Correspondence Information: Herschel Perel of Teva Pharmaceuticals USA
Trademarks Department
425 Privet Road
Horsham, Pennsylvania (PA) 19044
United States (USX)
The docket/reference number is 2977968.
The phone number is 215-293-6406.
The fax number is 215-293-6499.
The email address is herschel.perel@tevausa.com.
A fee payment in the amount of $100 will be submitted with the form, representing payment for 1 class(es), plus any additional grace period fee, if necessary.
Declaration
Unless the owner has specifically claimed excusable nonuse, the mark is in use in commerce on or in connection with the goods and/or services identified above, as evidenced by the attached
specimen(s) showing the mark as used in commerce.
The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements
and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own
knowledge are true and that all statements made on information and belief are believed to be true.
Signature: /herschel perel/ Date: 06/23/2011
Signatory's Name: Herschel Perel
Signatory's Position: Senior Director, Global Trademarks
Serial Number: 76573827
Internet Transmission Date: Thu Jun 23 10:17:08 EDT 2011
TEAS Stamp: USPTO/SECT08-XX.XXX.XXX.X-20110623101708
590698-2977968-48089b76549a9486ea64d2fee
1238967998-DA-9145-20110623100417342220